Blood loss during surgery.
Conditions
Interventions
Intervention 1: First intervention group:In group A in a 50 cc syringe 40 cc propofol with 0.15 µg / kg remifentanil is prepared and eventually the infusion at a dose of 50-150 µg/kg/min will be start
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ASA I, II patients who are candidates for DCR surgery Age range 18 to 80 years No contraindication for Hydralazine, Remifentanil and Propofol Consent to participate in the study
Exclusion criteria
Exclusion criteria: Known allergies to medicines Having heart disease Having diabetes mellitus Obvious anemia Having hemoglobinopathy Having polycythemia Having liver disease Ischemic cerebrovascular disease Having respiratory failure Systemic hypertension Any complication that may alter the anesthesia program Occurrence of complications such as heart block, etc. that prohibit or restrict the continuation of the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding volume. Timepoint: After intervention. Method of measurement: Suction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before and after intervention. Method of measurement: Non-invasive automatic barometer.;Heart rate. Timepoint: Before and after intervention. Method of measurement: Pulse Oximeter.;Length of staying in recovery. Timepoint: After intervention. Method of measurement: Modified Aldrete Score.;Surgeon satisfaction. Timepoint: After intervention. Method of measurement: likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Shetabi
Esfahan University of Medical Sciences
Outcome results
None listed